Kirsten Gillibrand Warns of Catastrophic Medicine Shortages in US-China Conflict

The Incalculable Cost of Medicine Shortages

• ⚠️ Kirsten Gillibrand warns that a war between the US and China could lead to catastrophic antibiotic shortages, potentially causing millions of American deaths.
• 💡 The long-term costs of medicine shortages, including productivity loss, delayed care, and substandard treatment, vastly outweigh any initial savings from cheaper, offshore drugs.
• 💰 A single shortage of one drug reportedly cost over $13 billion due to increased patient deaths from septic shock, a cost not borne by hospitals.

Supply Chain Vulnerabilities and Hospital Purchasing

• 🏭 Hospitals often lack visibility into supply chain risks and drug quality due to the absence of mandatory country of origin labeling.
• 📉 This lack of visibility forces hospitals to prioritize price over quality, inevitably pushing manufacturing offshore.
• 🎯 Purchasers, including the DoD and hospitals, often prioritize short-term cost decisions over long-term consequences.

National Security and Domestic Production

• 🚀 A war with China could cripple the US's ability to import antibiotics, with incalculable national security implications and potential trillions in costs.
• 🇺🇸 The US is unique among nations for not prioritizing its domestic manufacturing of essential goods.
• 📈 Strategies to redirect manufacturing through US-based procurement and prioritization are seen as having a higher probability of success than countering foreign production.

Solutions: Transparency, Incentives, and Domestic Investment

• 🏷️ Implementing country of origin labeling and requiring transparency from buyers can help shame the market into better participation.
• 🏭 The VA and DoD could lead by prioritizing